Six Years' Experience in Treatment of Chromomycosis with 5‐Fluorocytosine
- 1 June 1978
- journal article
- Published by Wiley in International Journal of Dermatology
- Vol. 17 (5) , 414-418
- https://doi.org/10.1111/ijd.1978.17.5.414
Abstract
Twenty‐three patients with chromomycosis were treated with oral 5‐fluorocytosine for periods ranging from 2 to 67 months. Sixteen were considered cured, after 3 consecutive monthly controls showing healing of the lesions and absence of fungi in mycologic and histopathologic examinations of biopsy specimens. Seven, in spite of initial clinical improvement, showed resistance to treatment. Associated treatment with amphotericin B, calciferol or thiabendazole failed to help patients resistant to 5‐fluorocytosine. Resistance seems to occur especially in those with long‐standing lesions or widespread involvement.Keywords
This publication has 4 references indexed in Scilit:
- Testes de susceptibilidade de agentes da cromomicose à 5-fluorocitosina e ao butil-simpatol (Vasculat)Revista da Sociedade Brasileira de Medicina Tropical, 1975
- IN VITRO SENSITIVITY TO 5-FLUOROCYTOSINE OF STRAINS ISOLATED FROM PATIENTS UNDER TREATMENT FOR CHROMOMYCOSISInternational Journal of Dermatology, 1975
- 5-Fluorocytosine Resistance in Cryptococcus neoformansAntimicrobial Agents and Chemotherapy, 1973
- In Vitro Studies of 5-Fluorocytosine Resistance in Candida albicans and Torulopsis glabrataAntimicrobial Agents and Chemotherapy, 1972